ITCI : Intra-Cellular Therapies stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-09-17 |
|---|---|---|---|---|
| 2024 | $70.06 | $69.03 | $71.67 | -6.73% |
| 2025 | $76.6 | $68.79 | $80.0 | 1.98% |
| 2026 | $65.46 | $52.6 | $78.37 | -12.84% |
| 2027 | $52.08 | $51.35 | $52.52 | -30.66% |
| 2028 | $48.65 | $40.47 | $53.75 | -35.23% |
| 2029 | $44.14 | $39.95 | $47.77 | -41.24% |
| 2030 | $51.72 | $47.8 | $59.78 | -31.14% |
| 2031 | $82.54 | $62.52 | $107.08 | 9.89% |
| 2032 | $110.84 | $93.85 | $121.15 | 47.57% |
| 2033 | $122.36 | $90.67 | $155.28 | 62.91% |
| 2034 | $166.66 | $158.2 | $170.98 | 121.89% |
The 30 Wall Street analysts offering Intra-Cellular Therapies stock forecast in the last 6 months have average price target of
$96.23 with a high forecast of $130.0 and a low forecast of $74.0.
The average Intra-Cellular Therapies stock forecast represents a 28.12%
increase from the last price of $75.1100006103516.
For Intra-Cellular Therapies stock forecast for 2024, 3 predictions are offered for each month of 2024 with average Intra-Cellular Therapies stock
forecast of $70.06, a high forecast of $71.67, and a low forecast of $69.03.
The average Intra-Cellular Therapies stock forecast 2024 represents a -6.73%
decrease from the last price of $75.1100006103516.
For Intra-Cellular Therapies stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Intra-Cellular Therapies stock
forecast of $76.6, a high forecast of $80.0, and a low forecast of $68.79.
The average Intra-Cellular Therapies stock forecast 2025 represents a 1.98%
increase from the last price of $75.1100006103516.
For Intra-Cellular Therapies stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Intra-Cellular Therapies stock
forecast of $52.08, a high forecast of $52.52, and a low forecast of $51.35.
The average Intra-Cellular Therapies stock forecast 2027 represents a -30.66%
decrease from the last price of $75.1100006103516.
For Intra-Cellular Therapies stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average Intra-Cellular Therapies stock
forecast of $44.14, a high forecast of $47.77, and a low forecast of $39.95.
The average Intra-Cellular Therapies stock forecast 2029 represents a -41.24%
decrease from the last price of $75.1100006103516.
For Intra-Cellular Therapies stock forecast 2030, 12 predictions are offered for each month of 2030 with average Intra-Cellular Therapies stock
forecast of $51.72, a high forecast of $59.78, and a low forecast of $47.8.
The average Intra-Cellular Therapies stock forecast 2030 represents a -31.14%
decrease from the last price of $75.1100006103516.
For Intra-Cellular Therapies stock forecast for 2034 (10 year), 9 predictions are offered for each month of 2034 with average Intra-Cellular Therapies stock
forecast of $166.66, a high forecast of $170.98, and a low forecast of $158.2.
The average Intra-Cellular Therapies stock forecast 2034 represents a 121.89%
increase from the last price of $75.1100006103516.
Please, see more forecasts below.
ITCI : Intra-Cellular Therapies stock forecast by Wall Street Analysts
The average Intra-Cellular Therapies stock forecast from last 6 month is $96.23, and this show a 5.76% increase in average from the prior price target of the each prediction. Also, this average forecast of $96.23 represents a 13.12% increase from the past average forecast of $85.07, 6 months ago from 14 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-09-16 | Cantor Fitzgerald | $130.00 | $130.0000 | Overweight |
| 2024-09-06 | Piper Sandler | $68.0000 | $92 | Overweight |
| 2024-08-21 | JP Morgan | $79.0000 | $81.0000 | Overweight |
| 2024-08-08 | Needham | $100.00 | $100.00 | Buy |
| 2024-08-08 | Goldman Sachs | $77.00 | $74 | Neutral |
| 2024-08-08 | UBS | $83.00 | $79.0000 | Neutral |
| 2024-08-08 | Cantor Fitzgerald | $120.00 | $130 | Overweight |
| 2024-08-08 | RBC Capital | $107.0000 | $106 | Outperform |
| 2024-08-07 | Needham | $100.00 | $100.00 | Buy |
| 2024-07-22 | Needham | $94.00 | $100 | Buy |
| 2024-06-25 | RBC Capital | $103.0000 | $103 | Outperform |
| 2024-06-25 | UBS | $85.0000 | $83.0000 | Neutral |
| 2024-06-21 | Mizuho | $96.00 | $100 | Buy |
| 2024-06-20 | Canaccord Genuity | $107.00 | $113.0000 | Buy |
| 2024-06-18 | Needham | $90.00 | $94.0000 | Buy |
| 2024-06-14 | Cantor Fitzgerald | $120.00 | $120.00 | Overweight |
| 2024-06-12 | JP Morgan | $75.0000 | $78 | Overweight |
| 2024-05-08 | Needham | $90.0000 | Buy | |
| 2024-05-07 | Needham | $90.0000 | Buy | |
| 2024-04-24 | Cantor Fitzgerald | $120 | Overweight | |
| 2024-04-23 | Canaccord Genuity | $100.00 | $107.0000 | Buy |
| 2024-04-22 | Mizuho | $82.00 | $96 | Buy |
| 2024-04-22 | Needham | $82.00 | $90 | Buy |
| 2024-04-17 | TD Cowen | $80.0000 | $90.0000 | Buy |
| 2024-04-17 | Baird | $83.00 | $103 | Outperform |
| 2024-04-17 | B of A Securities | $82.00 | $91.0000 | Buy |
| 2024-04-17 | Goldman Sachs | $67.0000 | $77 | Neutral |
| 2024-04-16 | Needham | $82.00 | Buy | |
| 2024-04-05 | Needham | $82.00 | Buy | |
| 2024-04-03 | RBC Capital | $86.0000 | Outperform | |
| 2024-02-23 | RBC Capital | $86.0000 | Outperform | |
| 2024-02-23 | Cantor Fitzgerald | $101.0000 | Overweight | |
| 2024-02-23 | Canaccord Genuity | $101.0000 | $100.0000 | Buy |
| 2024-02-23 | Needham | $72.00 | $82.0000 | Buy |
| 2024-02-16 | Mizuho | $76.00 | $82.0000 | Buy |
| 2024-01-31 | RBC Capital | $86.0000 | Outperform | |
| 2024-01-18 | Goldman Sachs | $58.0000 | $64 | Neutral |
| 2024-01-03 | Baird | $83.0000 | Outperform | |
| 2024-01-02 | B of A Securities | $74.0000 | $82 | Buy |
| 2023-12-14 | Cantor Fitzgerald | $101.0000 | Overweight | |
| 2023-12-11 | TD Cowen | $75.0000 | Outperform | |
| 2023-11-03 | RBC Capital | $77.0000 | $76.0000 | Outperform |
| 2023-11-03 | Needham | $71.0000 | $72 | Buy |
| 2023-11-03 | Cantor Fitzgerald | $98.00 | $101.0000 | Overweight |
Intra-Cellular Therapies stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-09-19 | $88.42 | 17.73% |
| 2024-09-20 | $94.50 | 6.87% |
| 2024-09-23 | $98.52 | 4.26% |
| 2024-09-24 | $101.92 | 3.45% |
| 2024-09-25 | $104.47 | 2.51% |
ITCI : Long term Intra-Cellular Therapies stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Oct. is $71.67 , for 2025 Sep. is $79.61 , for 2028 Sep. is $47.32 , for 2029 Sep. is $47.25 , for 2033 Sep. is $145.57 , and for 2034 Sep. is $170.78.
ITCI : Intra-Cellular Therapies stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Oct. | $71.67 | -4.58% |
| 2024 Nov. | $69.48 | -3.06% |
| 2024 Dec. | $69.03 | -0.64% |
ITCI : Intra-Cellular Therapies stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $68.79 | -0.35% |
| 2025 Feb. | $70.28 | 2.16% |
| 2025 Mar. | $71.65 | 1.95% |
| 2025 Apr. | $75.46 | 5.33% |
| 2025 May. | $78.10 | 3.49% |
| 2025 Jun. | $79.02 | 1.18% |
| 2025 Jul. | $79.44 | 0.53% |
| 2025 Aug. | $80.00 | 0.69% |
| 2025 Sep. | $79.61 | -0.48% |
| 2025 Oct. | $79.20 | -0.52% |
| 2025 Nov. | $78.92 | -0.35% |
| 2025 Dec. | $78.73 | -0.24% |
ITCI : Intra-Cellular Therapies stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $78.37 | -0.46% |
| 2026 Feb. | $77.73 | -0.81% |
| 2026 Mar. | $76.41 | -1.71% |
| 2026 Apr. | $74.17 | -2.92% |
| 2026 May. | $71.17 | -4.05% |
| 2026 Jun. | $67.48 | -5.19% |
| 2026 Jul. | $63.51 | -5.89% |
| 2026 Aug. | $59.76 | -5.91% |
| 2026 Sep. | $56.67 | -5.16% |
| 2026 Oct. | $54.50 | -3.84% |
| 2026 Nov. | $53.20 | -2.39% |
| 2026 Dec. | $52.60 | -1.11% |
ITCI : Intra-Cellular Therapies stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $52.46 | -0.26% |
| 2027 Feb. | $52.48 | 0.03% |
| 2027 Mar. | $52.52 | 0.08% |
| 2027 Apr. | $52.51 | -0.02% |
| 2027 May. | $52.40 | -0.22% |
| 2027 Jun. | $52.18 | -0.41% |
| 2027 Jul. | $51.92 | -0.50% |
| 2027 Aug. | $51.67 | -0.49% |
| 2027 Sep. | $51.45 | -0.41% |
| 2027 Oct. | $51.35 | -0.21% |
| 2027 Nov. | $51.56 | 0.42% |
| 2027 Dec. | $52.46 | 1.73% |
ITCI : Intra-Cellular Therapies stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $53.60 | 2.17% |
| 2028 Feb. | $53.75 | 0.29% |
| 2028 Mar. | $52.68 | -1.99% |
| 2028 Apr. | $51.15 | -2.91% |
| 2028 May. | $50.33 | -1.61% |
| 2028 Jun. | $49.59 | -1.47% |
| 2028 Jul. | $48.77 | -1.65% |
| 2028 Aug. | $47.88 | -1.84% |
| 2028 Sep. | $47.32 | -1.15% |
| 2028 Oct. | $46.14 | -2.50% |
| 2028 Nov. | $42.06 | -8.83% |
| 2028 Dec. | $40.47 | -3.79% |
ITCI : Intra-Cellular Therapies stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $39.95 | -1.29% |
| 2029 Feb. | $39.95 | 0.02% |
| 2029 Mar. | $40.41 | 1.13% |
| 2029 Apr. | $41.27 | 2.13% |
| 2029 May. | $42.42 | 2.80% |
| 2029 Jun. | $43.74 | 3.11% |
| 2029 Jul. | $45.09 | 3.08% |
| 2029 Aug. | $46.31 | 2.71% |
| 2029 Sep. | $47.25 | 2.03% |
| 2029 Oct. | $47.73 | 1.02% |
| 2029 Nov. | $47.77 | 0.07% |
| 2029 Dec. | $47.75 | -0.03% |
ITCI : Intra-Cellular Therapies stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $47.80 | 0.10% |
| 2030 Feb. | $47.91 | 0.24% |
| 2030 Mar. | $48.13 | 0.46% |
| 2030 Apr. | $48.51 | 0.79% |
| 2030 May. | $49.10 | 1.20% |
| 2030 Jun. | $49.92 | 1.67% |
| 2030 Jul. | $50.96 | 2.09% |
| 2030 Aug. | $52.20 | 2.42% |
| 2030 Sep. | $53.63 | 2.75% |
| 2030 Oct. | $55.32 | 3.15% |
| 2030 Nov. | $57.35 | 3.66% |
| 2030 Dec. | $59.78 | 4.24% |
ITCI : Intra-Cellular Therapies stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $62.52 | 4.58% |
| 2031 Feb. | $65.48 | 4.74% |
| 2031 Mar. | $68.71 | 4.93% |
| 2031 Apr. | $72.27 | 5.18% |
| 2031 May. | $75.95 | 5.09% |
| 2031 Jun. | $79.43 | 4.58% |
| 2031 Jul. | $82.99 | 4.49% |
| 2031 Aug. | $86.89 | 4.69% |
| 2031 Sep. | $91.29 | 5.07% |
| 2031 Oct. | $96.23 | 5.41% |
| 2031 Nov. | $101.59 | 5.57% |
| 2031 Dec. | $107.08 | 5.41% |
ITCI : Intra-Cellular Therapies stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $112.19 | 4.77% |
| 2032 Feb. | $116.43 | 3.78% |
| 2032 Mar. | $119.47 | 2.61% |
| 2032 Apr. | $121.15 | 1.40% |
| 2032 May. | $120.96 | -0.15% |
| 2032 Jun. | $118.53 | -2.01% |
| 2032 Jul. | $114.21 | -3.64% |
| 2032 Aug. | $109.79 | -3.88% |
| 2032 Sep. | $105.35 | -4.04% |
| 2032 Oct. | $100.98 | -4.15% |
| 2032 Nov. | $97.16 | -3.79% |
| 2032 Dec. | $93.85 | -3.40% |
ITCI : Intra-Cellular Therapies stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $91.31 | -2.71% |
| 2033 Feb. | $90.67 | -0.70% |
| 2033 Mar. | $92.95 | 2.52% |
| 2033 Apr. | $98.51 | 5.98% |
| 2033 May. | $106.86 | 8.47% |
| 2033 Jun. | $117.22 | 9.70% |
| 2033 Jul. | $128.46 | 9.59% |
| 2033 Aug. | $138.40 | 7.74% |
| 2033 Sep. | $145.57 | 5.18% |
| 2033 Oct. | $150.16 | 3.15% |
| 2033 Nov. | $152.92 | 1.84% |
| 2033 Dec. | $155.28 | 1.54% |
ITCI : Intra-Cellular Therapies stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $158.20 | 1.88% |
| 2034 Feb. | $161.32 | 1.98% |
| 2034 Mar. | $164.10 | 1.72% |
| 2034 Apr. | $166.35 | 1.37% |
| 2034 May. | $168.13 | 1.07% |
| 2034 Jun. | $169.55 | 0.84% |
| 2034 Jul. | $170.55 | 0.59% |
| 2034 Aug. | $170.98 | 0.25% |
| 2034 Sep. | $170.78 | -0.12% |
Frequently Asked Questions about Intra-Cellular Therapies stock forecast
Is Intra-Cellular Therapies a good long term stock?
From Intra-Cellular Therapies stock forecast , Intra-Cellular Therapies (ITCI) stock cannot be a good investment choice. According to AIPickup, the Intra-Cellular Therapies stock price forecast for 2024 Oct. is $71.6671531193498 From Intra-Cellular Therapies stock forecast , Intra-Cellular Therapies (ITCI) stock can be a good investment choice. According to AIPickup, the Intra-Cellular Therapies stock price forecast for 2025 Sep. is $79.6117493433974 From Intra-Cellular Therapies stock forecast , Intra-Cellular Therapies (ITCI) stock cannot be a good investment choice. According to AIPickup, the Intra-Cellular Therapies stock price forecast for 2028 Sep. is $47.3239510181258 From Intra-Cellular Therapies stock forecast , Intra-Cellular Therapies (ITCI) stock cannot be a good investment choice. According to AIPickup, the Intra-Cellular Therapies stock price forecast for 2029 Sep. is $47.2493622663001 From Intra-Cellular Therapies stock forecast , Intra-Cellular Therapies (ITCI) stock can be a good investment choice. According to AIPickup, the Intra-Cellular Therapies stock price forecast for 2033 Sep. is $145.571285984496 From Intra-Cellular Therapies stock forecast , Intra-Cellular Therapies (ITCI) stock can be a good investment choice. According to AIPickup, the Intra-Cellular Therapies stock price forecast for 2034 Sep. is $170.776138820811
Is Intra-Cellular Therapies stock overvalued?
Intra-Cellular Therapies (ITCI) stock is expected to go UP . Therefore, AIPickup would say that Intra-Cellular Therapies (ITCI) stock is NOT overvalued.
Will Intra-Cellular Therapies stock price go up?
Yes. The Intra-Cellular Therapies stock price forecast for 2025 Sep. is $79.6117493433974
Is Intra-Cellular Therapies stock a good buy now?
Since closing price on 2024-09-17 is $75.1100006103516 and forecast for 2025 Sep. is $79.61, Intra-Cellular Therapies stock is a good 1 year investment.
14 Days Historical Data for Intra-Cellular Therapies stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| ITCI stock price for 2024-08-28 | $72.77 | $73.70 | $72.42 | $73.74 |
| ITCI stock price for 2024-08-29 | $72.26 | $72.77 | $72.02 | $73.47 |
| ITCI stock price for 2024-08-30 | $73.28 | $72.27 | $72.21 | $73.48 |
| ITCI stock price for 2024-09-03 | $73.00 | $73.30 | $72.61 | $74.73 |
| ITCI stock price for 2024-09-04 | $72.66 | $72.61 | $71.75 | $73.09 |
| ITCI stock price for 2024-09-05 | $72.42 | $73.13 | $71.79 | $73.13 |
| ITCI stock price for 2024-09-06 | $73.54 | $74.89 | $73.02 | $76.12 |
| ITCI stock price for 2024-09-09 | $74.41 | $73.86 | $73.71 | $76.34 |
| ITCI stock price for 2024-09-10 | $73.56 | $74.80 | $73.22 | $75.16 |
| ITCI stock price for 2024-09-11 | $74.72 | $73.62 | $73.05 | $74.92 |
| ITCI stock price for 2024-09-12 | $75.22 | $74.55 | $74.10 | $75.85 |
| ITCI stock price for 2024-09-13 | $75.38 | $75.55 | $74.95 | $76.98 |
| ITCI stock price for 2024-09-16 | $75.26 | $75.75 | $75.21 | $76.60 |
| ITCI stock price for 2024-09-17 | $75.11 | $75.27 | $74.67 | $76.56 |